Cite

HARVARD Citation

    Paolino, K. et al. (2022). Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults. Vaccine. 40 (12), pp. 1864-1871. [Online]. 
  
Back to record